These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5526348)

  • 21. Clinical evaluation of L-asparaginase. Introduction.
    Burchenal JH; Karnofsky DA
    Cancer; 1970 Feb; 25(2):241-3. PubMed ID: 4905151
    [No Abstract]   [Full Text] [Related]  

  • 22. Entrapment of L-asparaginase in red blood cells. A strategy to improve treatment of acute lymphoblastic leukemia.
    Updike SJ
    Bibl Haematol; 1985; (51):65-74. PubMed ID: 4004765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guine pig liver L-asparaginase. Separation, purification, and intracellular localisation of two distinct enzymatic activities.
    Rogez JC; Plaquet R; Biserte G
    Biochim Biophys Acta; 1975 Dec; 410(2):370-81. PubMed ID: 1239300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-Asparaginase: discovery and development as a tumor-inhibitory agent.
    Broome JD
    Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374
    [No Abstract]   [Full Text] [Related]  

  • 25. L-asparaginase-antileukemia agent.
    Jabbar A; Yaqub M
    J Pak Med Assoc; 1976 Jun; 26(6):148-50. PubMed ID: 826661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of asparaginase preparations for the treatment of tumors and leukemia (review of the literature)].
    Nikolaev AIa
    Probl Gematol Pereliv Krovi; 1969 Jul; 14(7):51-60. PubMed ID: 4903458
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytostatic effect of L-asparaginase].
    Rakowska-Wódz A; Szyszka K; Abucewicz A
    Wiad Lek; 1970 Jan; 23(2):117-20. PubMed ID: 4985374
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased circulatory lifetime of the antileukemic enzyme L-asparaginase [proceedings].
    Foster RL; Wileman T
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():37P. PubMed ID: 42711
    [No Abstract]   [Full Text] [Related]  

  • 29. [The antitumor activity of L-asparaginase].
    Adamson RH; Fabro S
    Acta Vitaminol Enzymol; 1969; 23(3):111-24. PubMed ID: 4897937
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood level course in humans following administration of 2 various kinds of L-asparaginase].
    Pütter J; Gehrmann G
    Klin Wochenschr; 1969 Dec; 47(24):1324-6. PubMed ID: 5382022
    [No Abstract]   [Full Text] [Related]  

  • 31. Asparaginase and leukaemia.
    Haskell CM; Canellos GP
    Lancet; 1969 Mar; 1(7595):626. PubMed ID: 4180150
    [No Abstract]   [Full Text] [Related]  

  • 32. Response to highly purified L-asparaginase during therapy of acute leukemia.
    Hill JM; Loeb E; MacLellan A; Khan A; Roberts J; Shields WF; Hill NO
    Cancer Res; 1969 Aug; 29(8):1574-80. PubMed ID: 4896902
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on pH and thermal stability of novel purified L-asparaginase from Pectobacterium carotojorum MTCC 1428.
    Kumar S; Dasu VV; Pakshirajan K
    Mikrobiologiia; 2011; 80(3):349-55. PubMed ID: 21861371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective actions of Na+ and K+ from heat inactivation of L-asparaginase activity in certain samples of guinea pig serum.
    Ryoyama C
    Biochim Biophys Acta; 1971 Apr; 236(1):8-16. PubMed ID: 5577475
    [No Abstract]   [Full Text] [Related]  

  • 35. The asparaginase activities of bacteria.
    Wade HE; Robinson HK; Phillips BW
    J Gen Microbiol; 1971 Mar; 65(3):i. PubMed ID: 5556681
    [No Abstract]   [Full Text] [Related]  

  • 36. Basis for loss of therapeutic effectiveness of L-asparaginase in sensitized mice.
    Baechtel S; Prager MD
    Cancer Res; 1973 Aug; 33(8):1966-9. PubMed ID: 4578567
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased antitumor activity of Escherichia coli. L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y; Wada H; Yagura T; Nishimura H; Matsushima A; Inada Y
    Gan; 1982 Jun; 73(3):470-4. PubMed ID: 6751921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High molecular weight L-asparaginase derivatives based on a water-soluble carboxymethyl cellulose: biological properties].
    Karsakevich AS; Kinstler OB; Dauvarte AZh; Vina IA
    Vopr Med Khim; 1988; 34(3):107-10. PubMed ID: 3420797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y; Wada H; Yagura T; Matsushima A; Inada Y
    J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chemical modification of E. coli L-asparaginase by N,O-carboxymethyl chitosan.
    Qian G; Zhou J; Ma J; Wang D; He B
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):567-77. PubMed ID: 8922226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.